KIMBERLY CLARK CORP
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Chief Growth Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Growth Officer
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Chief Growth Officer
Restricted Share Units 7/31/24 (w/dividends reinvested)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief R&D Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief R&D Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief R&D Officer
Common Stock
Chief R&D Officer
Common Stock
Chief R&D Officer
Restricted Share Units 7/31/24 (2 Year)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief R&D Officer
Restricted Share Units 7/31/24 (w/dividends reinvested)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Controller, VP & FP&A
Common Stock
President, Int'l Personal Care
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
President, Int'l Personal Care
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
President, Int'l Personal Care
Common Stock
President, Int'l Personal Care
Restricted Share Units 5/01/2024 (w/Dividends reinvested)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President, Int'l Personal Care
Restricted Share Units 5/01/2025 (w/dividends reinvested)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President, Int'l Personal Care
Restricted Share Units 5/1/2026 (w/dividends reinvested)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President, North America
Restricted Share Units 5/1/2026 (w/dividends reinvested)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Human Resources Officer
Restricted Share Units 5/1/2026 (w/dividends reinvested)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Info & GBS Officer
Restricted Share Units 5/01/2026 (3 year)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Info & GBS Officer
Restricted Share Units 5/1/2026 (w/dividends reinvested)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Growth Officer | Common StockOption exercise or conversion | 966$0 reported · see filing | Not established | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief Growth Officer | Common StockExercise-price or tax withholding | 404$109.31 / share | $44.16K | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief Growth Officer | Restricted Share Units 7/31/24 (w/dividends reinvested)Option exercise or conversion | Derivative units966Exercise / conversion price not reported | Not a separate purchase | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief R&D Officer | Common StockOption exercise or conversion | 4,024$0 reported · see filing | Not established | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief R&D Officer | Common StockOption exercise or conversion | 1,255$0 reported · see filing | Not established | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief R&D Officer | Common StockExercise-price or tax withholding | 534$109.31 / share | $58.37K | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief R&D Officer | Common StockExercise-price or tax withholding | 1,711$109.31 / share | $187.03K | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief R&D Officer | Restricted Share Units 7/31/24 (2 Year)Option exercise or conversion | Derivative units4,024Exercise / conversion price not reported | Not a separate purchase | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Chief R&D Officer | Restricted Share Units 7/31/24 (w/dividends reinvested)Option exercise or conversion | Derivative units1,255Exercise / conversion price not reported | Not a separate purchase | Jul 31Filed Aug 4 · 4d later | SEC filing |
| Controller, VP & FP&A | Common StockSale | 4,095$98.00 / share | $401.31K | May 6Filed May 6 · 0d later | SEC filing |
| President, Int'l Personal Care | Common StockOption exercise or conversion | 1,740$0 reported · see filing | Not established | May 1Filed May 4 · 3d later | SEC filing |
| President, Int'l Personal Care | Common StockOption exercise or conversion | 1,716$0 reported · see filing | Not established | May 1Filed May 4 · 3d later | SEC filing |
| President, Int'l Personal Care | Common StockSale | 1,596$95.34 / share | $152.16K | May 4Filed May 4 · 0d later | SEC filing |
| President, Int'l Personal Care | Restricted Share Units 5/01/2024 (w/Dividends reinvested)Option exercise or conversion | Derivative units1,716Exercise / conversion price not reported | Not a separate purchase | May 1Filed May 4 · 3d later | SEC filing |
| President, Int'l Personal Care | Restricted Share Units 5/01/2025 (w/dividends reinvested)Option exercise or conversion | Derivative units1,740Exercise / conversion price not reported | Not a separate purchase | May 1Filed May 4 · 3d later | SEC filing |
| President, Int'l Personal Care | Restricted Share Units 5/1/2026 (w/dividends reinvested)Grant or award | Derivative units8,191Award · no purchase price | Non-cash award | May 1Filed May 4 · 3d later | SEC filing |
| President, North America | Restricted Share Units 5/1/2026 (w/dividends reinvested)Grant or award | Derivative units12,286Award · no purchase price | Non-cash award | May 1Filed May 4 · 3d later | SEC filing |
| Chief Human Resources Officer | Restricted Share Units 5/1/2026 (w/dividends reinvested)Grant or award | Derivative units5,119Award · no purchase price | Non-cash award | May 1Filed May 4 · 3d later | SEC filing |
| Chief Info & GBS Officer | Restricted Share Units 5/01/2026 (3 year)Grant or award | Derivative units17,917Award · no purchase price | Non-cash award | May 1Filed May 4 · 3d later | SEC filing |
| Chief Info & GBS Officer | Restricted Share Units 5/1/2026 (w/dividends reinvested)Grant or award | Derivative units7,167Award · no purchase price | Non-cash award | May 1Filed May 4 · 3d later | SEC filing |
Showing the latest 20 of 122 trades. Show all 122 trades
Kimberly-Clark Corporation - Common Stock (KMB) · Stock
The filing reports a sale for the member.
Kevin HernReporting House memberKimberly-Clark Corporation Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberKimberly-Clark Corporation Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberKimberly-Clark Corporation - Common Stock · Stock
The filing reports a purchase for the member.
Kimberly-Clark Corporation Common Stock (KMB) · Stock
The filing reports a sale for the member.
Gilbert CisnerosReporting House member